Skip to main content
Fig. 4 | Cancer Cell International

Fig. 4

From: Development and clinical validation of a novel six-gene signature for accurately predicting the recurrence risk of patients with stage II/III colorectal cancer

Fig. 4

Evaluation of the CRRS model in four cohorts. A Time-dependent ROC analysis for predicting RFS at 1 ~ 5 years. B The Harrell’s C-index of CRRS. C Calibration plots for comparing the actual probabilities and the predicted probabilities of RFS at 1 ~ 5 years. D Comparison of recurrence rate between the high-risk and low-risk groups. E ROC analysis of the CRRS model for predicting the recurrence event of patients

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us